Hypotension · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypotension · heart failure with chronic kidney disease
ACUTE: Serelaxin showed no clear difference in hypotension compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Time in moderate‐intensity physical activity · people with COPD, clinical stability
1 finding from 1 review
Time in moderate‐intensity physical activity · people with COPD, clinical stability
1 finding from 1 review
Intervention not reported
Time in moderate‐intensity physical activity · people with COPD, clinical stability
1 finding from 1 review
Intervention not reported
Change in time in moderate intensity physical activity · people with COPD, clinical stability
1 finding from 1 review
Maternal admission to intensive care · pregnant women, or those within 42 days of delivery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drinking Intensity · adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
1 finding from 1 review
Drinking Intensity · adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
195 participants
Very low
Drinking Intensity · adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
2 findings from 1 review
Drinking Intensity · adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
1 finding from 1 review
Hypertensive disorders (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) · women with gestational diabetes mellitus
Probiotic showed no clear difference in hypertensive disorders (including pre‐eclampsia, pregnancy‐induced… compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · women with persistent or prolonged retention of placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participation · children with cerebral palsy classified within GMFCS Levels I to V and between 3 and 18 years of age
1 finding from 1 review
Pruritus · chronic pruritus of unknown origin
Serlopitant 5 mg may leads to higher patient‐reported pruritus intensity compared with placebo (low certainty).
1 finding from 1 review
Pruritus · chronic pruritus of unknown origin
Serlopitant 0.25 mg showed no clear difference in patient‐reported pruritus intensity compared with placebo (low certainty).
1 finding from 1 review
Pruritus · chronic pruritus of unknown origin
Serlopitant 1 mg showed no clear difference in patient‐reported pruritus intensity compared with placebo (low certainty).
1 finding from 1 review
Persistent pulmonary hypertension · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Snoring intensity: endpoint score. · obstructive sleep apnoea
1 finding from 1 review
Snoring intensity: endpoint score. · obstructive sleep apnoea
1 finding from 1 review